GlaxoSmithKline’s Chief Executive To Retire Next Year

    GlaxoSmithKline (GSK) announced today that its CEO, Sir Andrew Witty, will retire on 31 March 2017. He has worked at the company for 32 years and became Chief Executive in 2008. GSK said that it will now conduct a formal

    The full content of this article is restricted to NamNews Subscribers. If you are an existing user, please log in below. Forgotten your password? Any problems logging in, contact us

    Existing Users Log In
     Remember Me